Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "mRNA-4157 (V940) Individualized Neoantigen Therapy + Pembro vs. Pembro in High-Risk Resected Melanoma"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Jeffrey Weber
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Jeffrey Weber
Login to view comments.
Click here to Login
Skin